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Objective: to determine whether the experience of the specialist team was associated with adverse events following
endovascular treatment of abdominal aortic aneurysms.
Methods: the EUROSTAR database is a voluntary registry of 2863 patients admitted to 93 hospitals in Europe with an
abdominal aortic aneurysm treated with endovascular stenting. Mortality, rupture and the need for secondary interventions
were the main outcomes.
Results: in patients who underwent endovascular stenting by the most experienced specialist teams the mortality rate was
40% lower than in those treated by the least experienced teams (adjusted hazard ratio 0.60, 95% confidence interval: 0.4±
1.0; p 0.05). Also patients treated by the most experienced specialist teams were 68% less likely to have adverse events
necessitating a secondary intervention than those treated by the least experienced teams (adjusted hazard ratio 0.32, 95%
confidence interval: 0.2±0.5; p5 0.001). The crude rupture rate was 0.1% among patients treated by the most experienced
specialist teams and 0.8% among those treated by the least experienced teams (p 0.74).
Conclusions: specialist teams with a high level of experience of endovascular abdominal aortic aneurysm stenting
encounter lower mortality rates and fewer adverse events leading to secondary interventions.
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One of the major developments in vascular surgery in
the past decade has been the introduction of endo-
vascular techniques for the treatment of abdominal
aortic aneurysms.1±3 The principal advantages of
endografts are the low procedural complication rate
including mortality and the rapid recovery associated
with their use, in comparison to open surgery even
in patients in poor medical condition.4±6 Currently,
several industrially made endografts are available.7
But only two, the Ancure Tube and Bifurcated Endo-
vascular Grafting Systems, made by Guidant Endo-
vascular Technologies, Inc., of Menlo Park, CA, U.S.A.
and the AneuRx (Bifurcated) Stent Graft System,
made by Medtronic AVE, of Santa Rosa, CA, U.S.A.,
are approved by the Food and Drug Administration
(FDA) for commercial use in the U.S.A. However,Please address all correspondence to: R. Laheij, UMC St Radboud,
Department of Medical Technology Assessment, PO Box 9101,
6500HB Nijmegen, The Netherlands.
1078±5884/02/020128  06 $35.00/0 # 2002 Elsevier Science Ltd. Alrecent developments following the commercial release
of the AneuRx and Ancure endograft systems in the
U.S. market showed that many questions remain to
be solved before endovascular repair can be accepted
as an a preferable alternative to conventional open
surgery.8
Although feasible, endovascular repair is a technic-
ally demanding procedure. As such, outcome may be
influenced by the experience of the specialist team
undertaking the procedure.9,10
In this study mortality, rupture, and secondary
interventions are related to the experience of teams
contributing to the EUROSTAR (European Collabora-
tors on Stent/graft aortic Aneurysm Repair) database.
Methods
Data collection
In the current EUROSTAR4,11±13 analysis, we studied
the records of patients who underwent endovascularl rights reserved.
Team Experience on Abdominal Aortic Aneurysms 129AAA repair between January 1994 and July 2000. Data
on these patients had been reported prospectively by
93 hospitals in 16 European countries. We excluded 91
patients with consent only from the analysis. 20 of
these patients had been admitted recently and will
be operated in the near future.
Study variables
Demographic, clinical, investigative and operative
data was collected. Follow-up take place at 1, 3, 6, 12
and 18 months and then yearly was complete for 95%
of patients. Outcomes of interest were death, second-
ary interventions and rupture. Secondary intervention
was categorised as: conversion to open repair, endo-
vascular, abdominal and extra-anatomic. For most of
the study variables missing data accounted for no
more than 5% of the observations; the exception
were the smoking classification (8.5% of patients had
missing data) and aortic neck diameter (12.7% of the
patients had missing data).
Statistical analysis
Experience of the specialist team was ranked in order
according to the accumulative number of operations
registered with EUROSTAR by each unit. The 25th,
50th and 75th percentiles were used as cutoff points
to define the experience levels. Tables comparing
patient characteristics and clinical features were gen-
erated according to level of experience. Chi-square
analysis was used to compare the base-line character-
istics of the subjects according to the experience of the
team. To correct for differences in length of follow-up
period between quartiles the probabilities of survival
and freedom of secondary interventions were esti-
mated by the Kaplan±Meier method. Cox proportion-
al hazard regression models were used to assess the
impact of the experience of the specialist team on the
associations of interest. The reference group was
the group of patients treated by the least experienced
specialist team (first quartile). In subsequent models,
we added sequentially demographic, clinical, mor-
phological, and endograft characteristics. We cor-
rected for the correlation between patients in the
same hospital. In case more than 5% of the data were
missing a dummy variable for the missing values was
added to the model. Because of the small numbers of
patients with a rupture we performed analysis by
regression analysis with respect to mortality and sec-
ondary intervention only. Statistical analysis wasperformed with SAS software (version 6.12, SAS insti-
tute, Inc. Cary, NY, U.S.A.).
Results
Base-line characteristics
We studied 2863 patients who underwent endovascu-
lar abdominal aortic aneurysm repair from 93 hospi-
tals in 16 European countries. 1412 patients were
followed for at least 1 year, 632 patients for 2 years,
235 patients for 3 years, and 85 patients for 4 years. On
average 32 patients (range 1±417) were treated per
centre. The lowest experience quartile were the first
11 patients, the second-lowest quartile patient 12±37,
the second-highest quartile patient 38 to 91 patients,
and the highest quartile patient 92 or more. So patients
from a center with more than 92 patients were classi-
fied according to the consecutive order of procedures
performed by the specialist team in the hospital in
all four quartiles. In a center with an experience of
for example 20 procedures, the first 11 patients
were classified in the first quartile and the remaining
nine patients in the second quartile. Demographic
and clinical characteristics of the patients in the
study, by experience of the specialist team are shown
in Table 1. A higher proportion of patients treated
by inexperienced specialist teams were unfit for
open surgery, current smoker, and had more often
complex anatomy, in particular smaller and angulated
aortic necks.
Survival
Overall, 257 patients (9%, 95% confidence interval:
8±10%) died during follow-up. The intra-operative
mortality rate was 3% (85 patients). The crude mortal-
ity rate was 13% among patients admitted to hospitals
in second-lowest quartile and 5% among those treated
by a specialist team in the highest quartile (Table 2).
Unadjusted Kaplan±Meier survival curves for quar-
tiles of experience showed a late survival advantage
at high-experience specialist teams (p 0.008). The
mortality rates remain significantly different between
the lowest and the highest quartile of experience after
adjustment for age, smoking status, unfit for open
surgery, previous laparotomy, aortic neck angulation,
aortic neck diameter, aneurysm diameter, device and
endograft type (adjusted hazard ratio 0.60, 95% con-
fidence interval: 0.4±1.0%; p 0.05) (Table 3). The dif-
ference in adjusted mortality rates between the lowest
and second-highest quartile of experience was alsoEur J Vasc Endovasc Surg Vol 24, August 2002
Table 1. Base-line characteristics of the study patients, according to the quartile of experience with endovascular
abdominal aortic aneurysm repair of the specialist team.
Characteristics Specialist team experience
No. of patients (%)
p-value
Quartile 1 Quartile 2 Quartile 3 Quartile 4
Demographic
No. of patients 718 714 719 712
Age 0.93
550 years 166 (25) 179 (27) 160 (24) 168 (25)
50±70 years 334 (25) 324 (25) 333 (25) 324 (25)
470 years 218 (25) 211 (24) 226 (26) 220 (25)
Male gender 655 (25) 666 (25) 657 (25) 659 (25) 0.32
Current smokers 187 (28) 200 (30) 193 (30) 126 (19) 0.001
Clinical
Unfit for open surgery 106 (30) 105 (30) 113 (32) 28 (8) 0.001
Previous laparotomy 175 (23) 170 (23) 195 (26) 208 (28) 0.07
Vascular morphology
Mean diameter aortic neck 0.001
520 mm 151 (27) 164 (30) 134 (24) 106 (19)
20±25 mm 308 (31) 272 (27) 223 (22) 203 (20)
425 mm 119 (28) 102 (24) 116 (27) 95 (22)
Neck angulated 195 (33) 147 (25) 128 (22) 125 (21) 0.001
Mean diameter aneurysm 0.02
550 mm 257 (27) 225 (24) 212 (22) 263 (28)
50±60 mm 225 (26) 224 (26) 230 (26) 192 (22)
460 mm 213 (22) 238 (25) 255 (27) 242 (26)
Aneurysm angulated 85 (28) 83 (27) 70 (23) 67 (22) 0.32
Endograft
Device model 0.003
AneuRx 166 (24) 155 (22) 177 (25) 209 (30)
EVT 39 (31) 37 (29) 47 (37) 4 (3)
Excluder 24 (18) 13 (10) 25 (18) 75 (55)
Stentor 135 (44) 83 (27) 55 (18) 37 (12)
Talent 67 (18) 88 (23) 123 (32) 105 (27)
Vanguard 260 (29) 280 (31) 222 (25) 131 (15)
Zenith 21 (9) 30 (13) 51 (21) 137 (57)
Other 6 (9) 28 (41) 19 (28) 15 (18)
Type 0.001
Bifurcated 662 (25) 673 (25) 649 (25) 667 (25)
Straight 40 (34) 36 (30) 22 (19) 21 (18)
Tapered 16 (17) 5 (5) 48 (52) 24 (26)
Table 2. Number of patients and events, according to the quartile of experience of the specialist
team.
Events Specialist team experience
No. of patients (%)
Quartile 1 Quartile 2 Quartile 3 Quartile 4
Death
30-day mortality 18 (3) 28 (4) 20 (3) 19 (3)
Overall mortality 83 (12) 89 (13) 51 (7) 34 (5)
Secondary interventions
Overall interventions 154 (21) 131 (18) 80 (11) 45 (6)
30 day conversion 18 (3) 22 (3) 8 (1) 10 (1)
Overall conversion 43 (6) 37 (5) 13 (2) 14 (2)
Transfemoral 104 (15) 85 (12) 55 (8) 23 (3)
Transabdominal 48 (7) 41 (6) 18 (3) 16 (2)
Extra-anatomic 23 (4) 15 (2) 15 (2) 7 (1)
Rupture
Overall rupture 6 (0.8) 5 (0.7) 4 (0.6) 1 (0.1)
Patients may have had events in more than one category.
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Table 3. Relative risk of death and need of secondary intervention among patients who underwent endovascular stenting, according to
the quartile of experience of the specialist team.
Model Hazard ratio (95% CI)
Quartile 2 Quartile 3 Quartile 4
Death
Unadjusted 1.37 (0.8±1.5) 0.76 (0.5±1.1) 0.64 (0.4±1.0)
Adjusted for demographic characteristics 1.13 (0.8±1.5) 0.80 (0.6±1.2) 0.64 (0.4±1.0)
Adjusted for demographic and clinical characteristics 1.11 (0.8±1.5) 0.78 (0.5±1.1) 0.70 (0.5±1.1)
Adjusted for demographic and clinical characteristics
and vascular morphology
1.07 (0.8±1.5) 0.71 (0.5±1.0) 0.69 (0.4±1.1)
Adjusted for demographic and clinical characteristics,
vascular morphology and endograft characteristics
1.03 (0.7±1.4) 0.61 (0.4±0.9) 0.60 (0.4±1.0)
Secondary interventions
Unadjusted 0.85 (0.7±1.1) 0.58 (0.4±0.8) 0.39 (0.3±0.6)
Adjusted for demographic characteristics 0.78 (0.6±1.0) 0.56 (0.4±0.7) 0.36 (0.3±0.5)
Adjusted for demographic and clinical characteristics 0.79 (0.6±1.0) 0.55 (0.4±0.7) 0.35 (0.3±0.5)
Adjusted for demographic and clinical characteristics
and vascular morphology
0.78 (0.6±1.0) 0.55 (0.4±0.7) 0.32 (0.2±0.5)
Adjusted for demographic and clinical characteristics,
vascular morphology and endograft characteristics
0.80 (0.6±1.0) 0.53 (0.4±0.7) 0.32 (0.2±0.5)
First quartile is reference group (Hazard ratio 1).
Demographic characteristics included age and smoking status.
Clinical characteristics included unfit for open surgery and previous laparotomy.
Vascular morphology include aortic neck angulation, aortic neck and aneurysm diameter.
Endograft characteristics include device type and configuration.
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confidence interval: 0.4±0.9%; p 0.02).
Rupture
A total of 16 out of 2863 patients (0.6%, 95% Confi-
dence Interval: 0.3±0.8%) suffered rupture of their
aneurysm at an average of 15 months after implant-
ation of the endograft (Table 2). Ten patients were
treated with a Vanguard endograft, the other patients
with a rupture were treated with a, Talent (2 patients),
Stentor (2 patients), AneuRx (1 patient) and Lifepath
(1 patient) endograft. The crude rupture rate was
0.8% among patients treated by specialist teams in
the lowest quartile and 0.1% among those treated by
a specialist team in the highest quartile ( p 0.74).
Secondary interventions
In 410 patients (14%, 95% Confidence Interval:
13±16%) some form of secondary intervention was
undertaken post-operatively. The reasons for second-
ary interventions were endoleak, migration of the
endograft, kinking of the endograft, aortic rupture,
stenosis and thrombosis.14 The majority of secondary
repairs (267 patients) were transfemoral (9.3%). In 107
patients (3.7%) conversion to open repair was neces-
sary. Kaplan±Meier curves for quartiles of experience
showed that interventions were undertaken morefrequently in patients treated by specialist teams with
the least experience (p 0.001). The crude secondary
intervention rate was 21% among patients treated by
specialist teams in the lowest quartile and 6.3% among
those treated by a specialist team in the highest quar-
tile. The association between the need for secondary
interventions and experience remained significant
after adjustment for follow-up, patient and device
characteristics (Table 3). For all the subgroups we
examined, the rates of secondary intervention
declined with increasing experience of the specialist
team.
Discussion
Post-operative mortality and secondary interventions
were respectively, 40% and 68% lower in patients
treated by the most experienced specialist teams com-
pared with the least experienced teams. This equals a
difference in mortality and secondary intervention
rates between these quartiles of 3.6 deaths and 9.7
secondary interventions per 100 patients respectively.
These differences were independent of patient selec-
tion, endograft characteristics (type and model of
stent) or follow-up period.15±19 There were too few
ruptures to permit conclusions to be drawn. In add-
ition, it appears that inexperienced teams may be
overambitious with regard to the selection of patients
with unfavourable anatomic characteristics and poor
medical conditions.Eur J Vasc Endovasc Surg Vol 24, August 2002
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accounted for some of the variation15,16 between
the groups of specialist teams, team experience (inad-
equate training and minimal supervision) appeared to
be of major importance in preventing adverse events
leading to secondary interventions and mortality. Pres-
ent data suggest there may be a threshold of proce-
dures for mortality between the second and third
quartile (38 patients), while for secondary interven-
tions this might be even higher than the highest quar-
tile (92 patients). This prolonged duration of the
learning curve17±19 suggests that surgeons and/or
radiologist starting to perform this procedure need to
operate upon many more patients under supervision
than is currently the case.
Also, data suggest that these operations should be
performed by experienced specialist teams only and
that considerably more `` training'' is required before
teams can be considered `` experienced'' than is cur-
rently considered acceptable. Therefore, there are
strong arguments in favor of centralising endovascu-
lar abdominal aneurysm stenting in units specializing
in the technique and with sufficient number of opera-
tions to optimise the results. Furthermore, one should
not start endovascular surgery of abdominal aortic
aneurysms unless it is likely that sufficient numbers
of procedures will be performed annually.20
In conclusion, mortality and adverse events leading
to secondary intervention after endovascular abdom-
inal aortic aneurysm repair were significantly lower in
patients who underwent endovascular abdominal aor-
tic aneurysm repair by a highly experienced specialist
team of vascular surgeons and intervention radiolo-
gists than in those who underwent endovascular
stenting by a relatively inexperienced team.
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